Sign in
Karina Fedasz

Karina Fedasz

Interim Chief Executive Officer and Interim Chief Financial Officer at Onconetix
CEO
Executive

About Karina Fedasz

Interim CEO and Interim CFO of Onconetix (principal executive and principal financial/accounting officer), appointed Interim CFO on June 10, 2024 and Interim CEO on April 2, 2025; age 52; MBA (Finance) from Columbia Business School, BA from UCLA; inactive CPA (CA) . Background spans capital raising, forecasting, M&A, and operating finance across media/technology/biotech, including roles at Evofem Biosciences (Head of Business Development), IDW Media (including CFO, managed IPO), and MOCEAN (CFO) . No TSR, revenue, or EBITDA performance metrics tied to her compensation are disclosed in ONCO’s proxy filings reviewed .

Past Roles

OrganizationRoleYearsStrategic impact
Various clients (incl. non-profit; early-stage AI/data-driven health & wellness tracker)ConsultantJan 2023 – Jun 2024Supported capital raising, modeling/forecasting, cash flow management, M&A advisory
Evofem Biosciences (Nasdaq)Head of Business DevelopmentFeb 2022 – Dec 2022Business development in women’s health biotech
IDW Media HoldingsRoles incl. Chief Financial OfficerAug 2019 – Oct 2021Managed company’s initial public offering; led finance in media company context
MOCEANChief Financial OfficerApr 2018 – Aug 2019Finance leadership at integrated agency for entertainment/gaming/brands

External Roles

Not disclosed in Onconetix filings reviewed (executive biography, governance, and compensation sections) .

Fixed Compensation

  • Fedasz was engaged via a consulting agreement upon her Interim CFO appointment; she later assumed Interim CEO responsibilities with no incremental compensation .
ComponentTermsEffective dates
Consulting fee (Interim CFO)$15,000 per month for up to 80 hours of monthly service Jun 10, 2024 – one-year term, terminable by either party with 30 days’ notice
Signatory services$2,500 per month Jun 10, 2024 – one-year term
Incremental pay on CEO appointmentNone (no additional compensation when appointed Interim CEO) Apr 2, 2025
Summary Compensation (Named Executive Officers)2024
Salary ($)$197,125
Bonus ($)— (not disclosed for Fedasz)
Stock awards ($)— (none disclosed for Fedasz)
Option awards ($)— (none disclosed for Fedasz)
All other compensation ($)— (none disclosed for Fedasz)

Additional company-wide compensation context for benchmarking:

  • Former CFO Bruce Harmon’s employment agreement contemplated $325,000 base and 30% target bonus; he received $66,153 severance upon resignation .
  • Former CEO Neil Campbell’s agreement contemplated $475,000 base and 50% target bonus; he received $158,333 severance after resignation .

Performance Compensation

  • No bonus plan, PSU/RSU, or options were disclosed for Fedasz in 2024; no additional compensation on CEO appointment, and no outstanding executive equity awards as of 12/31/2024 .
  • Company compensation plans (Equity Incentive Plans) are in place, but there is no disclosure of Fedasz-specific performance award metrics, targets, or payouts for 2024 .

Clawback policy: Adopted January 17, 2024, compliant with Exchange Act Section 10D and Nasdaq listing standards; covers recovery of erroneously awarded incentive compensation to officers after accounting restatements, for the prior three completed fiscal years .

Equity Ownership & Alignment

Ownership detailStatus
Beneficial ownership (as of Oct 21, 2025 record date)Not listed as a beneficial owner; table shows “-” for number of shares and percentage for Karina M. Fedasz
Vested vs unvested sharesNone disclosed (no awards outstanding for named executives at 12/31/2024)
Options (exercisable/unexercisable)None disclosed for Fedasz
Shares pledged as collateralNot disclosed in filings reviewed
Stock ownership guidelines (executives)Not disclosed in filings reviewed

Implications:

  • Minimal “skin in the game” and no near-term vesting cadence reduce insider-selling pressure but weaken alignment and retention incentives absent new equity grants .

Employment Terms

ItemDetail
Interim CFO appointmentEffective June 10, 2024
Interim CEO appointmentEffective April 2, 2025
Current titles and officer certificationsInterim CEO and Interim CFO (principal executive and principal financial/accounting officer); executed SOX 302 and 906 certifications for Q3 2025 10-Q
Contract structureConsulting agreement (one-year term; either party can terminate with 30 days’ written notice)
Cash compensation terms$15,000/month for up to 80 hours of service; $2,500/month signatory services
Change-in-role economicsNo additional compensation granted upon appointment as Interim CEO
Severance / CoCNo Fedasz-specific severance or change‑in‑control terms disclosed; plan-level equity treatment on corporate transactions described, but no outstanding awards for her at FY‑end 2024

Risk Indicators and Context Relevant to Compensation/Retention

  • Listing and capital structure: Company undertook a reverse stock split (Board-authorized range 1-for-10 to 1-for-150; later executed at 1:85) to address Nasdaq bid-price deficiency and maintain listing; ongoing capital raises via Series D/E Preferred and warrants require shareholder approval to unlock full anti-dilution adjustments and facilitate conversions/exercises .
  • Internal control environment and auditor turnover: Material weaknesses disclosed across 2023–2024 (segregation of duties, control precision, expense approvals, related-party processes, ITGC); auditor changed from EisnerAmper to MaloneBailey in Feb 2025 . These factors increase scrutiny on executive certifications and can influence clawback exposure and incentive design .
  • Liquidity and debt: Multiple forbearance/waiver agreements with Veru on legacy notes; amendment/restatement increased principal on a Veru note; Keystone short-term financing with subordination and mandatory prepayment mechanics—together point to tight liquidity and financing dependencies during Fedasz’s interim tenure .
  • Governance dynamics: Executive chair changes (Sapirstein appointed Executive Chairman Feb 2025, then resigned Mar 28, 2025), Board composition changes, and Fedasz dual‑hatting as CEO/CFO concentrate accountability and may impact succession and retention planning .

Compensation Structure Analysis

  • Cash-heavy, consulting-based compensation with no disclosed performance bonus or equity for 2024 indicates limited pay-for-performance linkage at the executive level for Fedasz in the period reviewed .
  • No incremental compensation upon elevation to Interim CEO further underscores cash cost-containment but may under-incentivize long-term value creation without subsequent equity grants .
  • Clawback adoption aligns with best practices and investor expectations for any future incentive pay .
  • Absence of outstanding equity and zero reported beneficial ownership diminishes alignment and could elevate retention risk in a turnaround/capital constrained context unless addressed prospectively .

Investment Implications

  • Alignment and retention: Fedasz currently has no disclosed equity ownership or outstanding awards; near-term selling pressure is minimal, but so is alignment—watch for post‑meeting equity grants or program changes that add performance‑linked equity and ownership guidelines .
  • Certification and controls: Dual‑hat CEO/CFO structure, auditor change, and disclosed material weaknesses heighten execution risk around financial reporting; clawback policy mitigates some downside but reinforces importance of tightening controls under her certifications .
  • Capital structure overhang: Series D/E anti‑dilution, floor prices, and warrant mechanics create equity overhang and potential dilution; outcomes of shareholder approvals and subsequent conversions/exercises are key near‑term stock drivers that intersect with compensation affordability and retention levers .
  • Governance/succession: Interim status, consulting agreement with 30‑day termination right, and no added CEO pay suggest flexibility but also potential continuity risk until a permanent structure and incentive framework are formalized .